All
Making Progress for Myelodysplastic Syndrome
July 25th 2017In an interview with CURE, Rami Komrokji, M.D., a hematologist at Moffitt Cancer Center in Tampa, Florida, discusses the advances that have been made in MDS in the past few years, as well as the MDS Clinical Research Consortium and its importance.
FDA Approves Yervoy for Pediatric Melanoma Population
July 24th 2017Yervoy (ipilimumab) was granted approval by the Food and Drug Administration (FDA) for the treatment of pediatric patients who are 12 years old or younger and have unresectable or metastatic melanoma, according to Bristol-Myers Squibb (BMS), the manufacturer of the CTLA-4 inhibitor.
Sexual Intimacy After Breast Cancer, a Taboo Subject
July 24th 2017Sexual intimacy is a subject that is difficult for many breast cancer survivors to discuss. The challenges of sexual intimacy are often created as a direct result of cancer treatments or can occur from the after effects which result in emotional scarring.
Immunotherapy May Move Into Advanced Gynecologic Cancers
July 20th 2017The immunotherapy agent Opdivo (nivolumab) showed clinical acitivty in women who had recurrent/metastatic cervical cancer, and was active to a lesser extent in vaginal and vulvar cancers, according to results from the CheckMate-358 trial.
What’s Next for Drug Price Reforms in Oncology?
July 19th 2017“If you locked everybody in a room for a week, I think we could come up with something that everybody would be comfortable with,” said Blase Polite, M.D., a co-author of the statement, and immediate past chair of ASCO’s government relations committee.
When Is It Time To Find a New Oncologist?
July 18th 2017The doctor-patient relationship is a delicate one. It's one that needs to be comfortable between both parties. When and how do breast cancer patients know when it's time to make a change? This is an important decision that should not be taken lightly.